| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Lillie James Woodruff is a Chief Scientific Officer at MPLT. Recent filings cover 0 purchases and 9 sales. Those positions are worth an estimated $2.5M at current prices.
Lillie James Woodruff's largest disclosed position is in MPLT as Chief Scientific Officer, worth about $2.5M. The recent filings there lean toward selling, a net 41,070 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | MPLT Maplight Therapeutics, Inc. | Chief Scientific Officer | Sell | 22,082 | $12.54 | $276,908.28 | -9.8% | - | - | |
| Jul 17, 2026 | MPLT Maplight Therapeutics, Inc. | Chief Scientific Officer | Sell | 18,267 | $36.88 | $673,636.18 | -1.1% | - | - | |
| May 7, 2026 | MPLT Maplight Therapeutics, Inc. | Chief Scientific Officer | Sell | 721 | $28.28 | $20,389.88 | -0.3% | -55.4% | - |